Novavax Inc. Stock Slides 12.2%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Novavax Inc. tumbled 12.2% to $11.26 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 2.1% to 26,140.03 and Dow Jones Industrial Average falling 0.3% to 52,002.41.

Novavax Inc. closed 15.9% short of its 52-week high of $13.39, which the company achieved on October 5th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 0.9% to $255.56, Pfizer Inc. rose 0.5% to $29.58, and Merck & Co. Inc. rose 0.52% to $145.95.

Trading volume totaled 9.9 million, compared to the 50-day average of 6.6 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 16, 2026 16:33 ET (20:33 GMT)